Kava kava

Kava kava

Best for

Lower day-to-day anxiety

Proven but unnoticeable · 300 mg/day for 4–13 weeks · 1 meta-analysis , n=585

3 papers · 3 claims · 2 outcomes scored · 3 positive

Outcomes

What kava kava actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Lower day-to-day anxiety Proven but unnoticeable
trivial
2 meta-analyses n=585 Meta-analyzed 300 mg 4–13 wk #5/48
Ease anxiety in older adults Proven but unnoticeable
trivial
2 meta-analyses n=585 Meta-analyzed 300 mg 4–13 wk #5/45
Reduce pre-competition anxiety Proven but unnoticeable
trivial
2 meta-analyses n=585 Meta-analyzed 300 mg 4–13 wk #5/45

Risk profile

Adverse events and known drug interactions

Safety events

hepatocellular necrosis severe
hepatotoxicity severe
angioedema severe
hepatic necrosis severe
cholestatic hepatitis severe
serotonin syndrome severe
seizure (including withdrawal seizures in heavy users) severe
rhabdomyolysis severe

Drug interactions

Alprazolam major increases effect
Acetaminophen major increases toxicity
Alprazolam major increases effect
other major increases concentration
Duloxetine major increases concentration
Venlafaxine major increases concentration
Antidepressants moderate increases effect
Levodopa moderate decreases effect
other moderate unknown
Unknown Specific Drugs (Class-Level Warning) moderate increases toxicity

Want personalized recommendations?

Show me what works for me